Ozone Therapy in Patients With Diabetic Neuropathy

Status Not yet recruiting

Clinical Trial Summary

Diabetic neuropathies are the most prevalent chronic complications of diabetes mellitus. The early recognition and appropriate management of neuropathy in the patient with diabetes is important for patient's quality of life and life expectancy. Ozone is well known to have anti-inflammatory and analgesic effects through the inhibition of pro-inflammatory mediators; as well as. stimulation of anti-inflammatory mediators' release

Clinical Trial Description

Introduction: Diabetic neuropathies are the most prevalent chronic complications of diabetes mellitus. The early recognition and appropriate management of neuropathy in the patient with diabetes is important for patient's quality of life and life expectancy. The clinical symptoms of DPN range from pain and burning sensations (at rest or at night) to hypoesthesia, paresthesia, and/or numbness . Diabetic neuropathy can be axonal or demyelinating and can affect large or small neurons. Schwann cells, which are the most abundant glial cells, act as nerve axon insulators and modulators of neurobiology through their role in metabolic support and injury protection. In diabetic patients, church cells' function is disturbed, leading to loss of glial-axon communication and nerve homeostasis, which leads to fiber loss, neurodegeneration, and pain. Nerve conduction studies can detect these changes; however, there has been no effective therapy for the treatment of DPN until now. Ozone is well known to have anti-inflammatory and analgesic effects through the inhibition of pro-inflammatory mediators; as well as. stimulation of anti-inflammatory mediators' release . Previous studies showed that Ozone promotes peripheral vascular integrity via induction of Vascular Endothelial Growth Factor (VEGF), Transforming Growth Factor Beta (TGF-β1) an Platelet-Derived Growth Factor (PDGF), according with the studies of Professor Bocci that demonstrated significantly increase and release of PDGF, TGF- β1 and VEGF in presence of Ozone . ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05000463
Study type	Interventional
Source	Assiut University
Contact	Emad Kamel, MD
Phone	+201007046058
Email	emadzarief@aun.edu.eg
Status	Not yet recruiting
Phase	N/A
Start date	February 25, 2022
Completion date	September 20, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05452499` - Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With Sequelae	N/A
Recruiting	`NCT05037682` - Pain and Opioid Management in Older Adults	N/A
Completed	`NCT04080037` - Assessing Opioid Care Practices Using CPV Patient Simulation Modules	N/A
Recruiting	`NCT05382962` - iCanCope With Post-Operative Pain (iCanCope PostOp)	N/A
Recruiting	`NCT04285112` - SPRINT: Signature for Pain Recovery IN Teens
Active, not recruiting	`NCT04850079` - EHR Precision Drug Treatment in Neonates
Completed	`NCT03271151` - Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty	Phase 4
Completed	`NCT03272139` - Interscalene Block Versus Superior Trunk Block	Phase 4
Completed	`NCT03886142` - Platelet Rich Plasma Versus Radio Frequency for Chronic Knee Arthritis	N/A
Recruiting	`NCT05761392` - APP-based Precise Management System of Chronic Intractable Pain	N/A
Recruiting	`NCT05877157` - Pain AND Opioids After Surgery
Completed	`NCT03947749` - Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain
Completed	`NCT03280017` - Ketamine With Multilevel Paravertebral Block for Post Video-assisted Thoracic Surgery Pain	Phase 4
Recruiting	`NCT04874038` - Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)	Phase 3
Completed	`NCT04280796` - Changes in Affective Pain Processing in Human Volunteers	N/A
Withdrawn	`NCT05125978` - Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain	Phase 2
Not yet recruiting	`NCT04328805` - Pain Reduction and Changes in Upper Limb Function Produced by an Ibuprofen Treatment in Carpal Tunnel Syndrome.	Phase 4
Completed	`NCT04976738` - A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain	Phase 1/Phase 2
Completed	`NCT04089618` - Meditation Based Lifestyle Modification in Chronic Pain	N/A
Recruiting	`NCT05699837` - Alpha Entrainment for Pain and Sleep (Extension)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.